Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 75.48

+1.4%

Nov 14 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (273)	2/10/2003 12:41:18 PM
From: Jibacoa	Read Replies (2) of 3722

IMCL Is up 10.44% on volume of 1,733,782, already ahead of its daily average. The stock was raised today to "buy" from "market perform" by Thomas Weisel. And last week it said it will make Erbitux available to "terminally ill" colon Ca. patients under the FDA's "compassionate use program". It has not shown any tendency to close Friday's up-gap.<g> siliconinvestor.com The stock at 10.37 is trading above Friday's H of 10.15 but it needs to close above its January 14 H of 12.20 before it can test its heavy resistance from November in the 15.40 to 15.50 area (Of course that would be a good % gain from present levels.<g>) siliconinvestor.com From a longer term perspective the R/R seems favorable. (Perhaps it is time for Martha to buy back.<g>) siliconinvestor.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next